Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with pruritic papular eruption of human immunodeficiency virus infection in the antiretroviral therapy era.

The British journal of dermatology·2014
Same author

Adverse effects of nevirapine.

Lancet (London, England)·2001
Same author

Treatment of AIDS and HIV-related conditions: 2001.

The Journal of the American Board of Family Practice·2001
Same author

Combination antiretroviral therapy: health care providers confront emerging dilemmas.

AIDS care·2000
Same author

Pneumocystis carinii pneumonia in HIV-infected patients.

American family physician·2000
Same author

Treatment of AIDS and HIV-related conditions: 2000.

The Journal of the American Board of Family Practice·2000

Related Experiment Video

Updated: Jul 12, 2026

Zika Virus Specific Diagnostic Epitope Discovery
11:37

Zika Virus Specific Diagnostic Epitope Discovery

Published on: December 12, 2017

Postexposure prophylaxis for occupational exposure to HIV

D Bangsberg, R H Goldschmidt

    JAMA
    |November 30, 1999
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
    06:02

    Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

    Published on: September 13, 2018

    Engineering Antiviral Agents via Surface Plasmon Resonance
    13:00

    Engineering Antiviral Agents via Surface Plasmon Resonance

    Published on: June 14, 2022

    Related Experiment Videos

    Last Updated: Jul 12, 2026

    Zika Virus Specific Diagnostic Epitope Discovery
    11:37

    Zika Virus Specific Diagnostic Epitope Discovery

    Published on: December 12, 2017

    Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
    06:02

    Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

    Published on: September 13, 2018

    Engineering Antiviral Agents via Surface Plasmon Resonance
    13:00

    Engineering Antiviral Agents via Surface Plasmon Resonance

    Published on: June 14, 2022